Spain moves to decentralise medtech R&D (research and development) with new E9 million centre:
This article was originally published in Clinica
Spain is to establish a new national regenerative medicine research centre in Barcelona, in line with a new national policy to decentralise healthcare R&D. Under an agreement signed between the Spanish health ministry and the Catalan regional government, the centre will be responsible for creating stem cell lines of embryonic and adult origin, as part of a national R&D programme that it will be responsible for devising in this area. The centre will be based at the biomedical research park of Barcelona (RRBB) and receive central funding totalling euro9m ($10.9m) by 2007.